Global Skin México

What Global Skin México does

Global Skin México is the Mexican distribution subsidiary of Global Skin Latinoamerica, a Panama-headquartered (founded 2002) private aesthetic medical product distributor operating across 11 Latin American countries. The company distributes a portfolio of proprietary and licensed brands to medical professionals — including Fillderm (DCL hyaluronic acid dermal fillers), Nabota (FDA/EMA/KFDA-approved 98.7% purity botulinum toxin), Duraform (PCL-HA ICH biostimulators), Bellalift (PCL suspension threads), Seduskin (PDRN, HA, collagen regenerative line), Kelo-cote (silicone scar gel), Simildiet (phytotherapeutic peelings/mesotherapy), Promedic (recombinant collagenase enzymes), Bioage (dermocosmetics), and Olidia — manufactured primarily through Laboratoire Global Skin France. Products target dermatologists, plastic surgeons, and aesthetic physicians for non-surgical facial rejuvenation, skin regeneration, scar management, biostimulation, and body contouring, with clinical evidence published in PRIME Journal.

The business runs an enterprise B2B model: direct field sales reps visit clinics and conduct workshops, supplemented by country-affiliated distributor networks and pharmacy distribution for OTC items (Kelo-cote). Revenue mechanics are not publicly disclosed; pricing is set per medical sales representative interaction. The company invests heavily in medical education via the Academia Internacional de Dermo Cosmetría (e.g., Bioage Convention 2024 trained 170 cosmetologists, dermatologists, and physiotherapists), and participates in international congresses (AMWC Monaco 2026, Baku Derma 2026) to maintain brand presence. Global Skin México specifically was launched in May 2024 under CEO Dr. Jamel Fares, bringing Promedic, Duraform, and lidocaine-containing HA filler to the Mexican medical community, and the firmographic record indicates a small headcount of 5 employees consistent with a recently established subsidiary entity.

The underlying technology platform centers on proprietary biomaterial formulations rather than software: DCL (Double Cross Linked) technology in HA fillers, ICH (Innovation Concept Hybrid) combining polycaprolactone microspheres with HA, the HYLAS regenerative stack (Hyladerm 2% HA, Hylagen3 collagen I/III, HYLA-PDRN salmon-derived polynucleotides), and botanical exosome technology (Camellia japonica). These differentiate Global Skin from generic HA filler distributors in Latin America and underpin the peer-reviewed clinical evidence base (e.g., 200-patient Duraform study with 80% satisfaction over 720 days, 80-woman Fillderm multicenter study). The combination of regulatory-grade manufacturing in France, clinical publication pipeline, and a 22-year regional distribution footprint constitutes the core competitive position, with the Mexico subsidiary representing a 2024-stage growth lever on top of an established parent operation.

Name

Global Skin México

Legal name

Global Skin Latinoamerica

Website

https://globalskinint.com

Company type

Private

Founded year

2002

Operating status

Operating

Short description

Global Skin México is a Mexican aesthetic medical product distribution subsidiary (launched 2024) of Global Skin Latinoamerica, selling proprietary dermal fillers, biostimulators, regenerative skincare, and scar treatments directly to dermatologists, plastic surgeons, and aesthetic physicians across Latin America.

Ownership category

akta.pro rank

Product category

Medical Aesthetic Distribution

NAICS

Pharmaceutical Preparation Manufacturing (325412), Health and Personal Care Retailers (4561)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro industry

PRIMARYHLAIACAL

Dermatology Specialty Pharmaceuticals

Healthcare & Life Sciences/Pharmaceuticals/Specialty Pharmaceuticals

SECONDARYCRABAAAF

Dermocosmetics & Medical-Grade Skincare

Consumer Products & Retail/Beauty & Personal Care/Skincare

SECONDARYHLAIAAAK

Dermatology & Aesthetics Pharmaceuticals

Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

SECONDARYCRABAAAK

Professional/Backbar Skincare (Esthetician & Spa Use)

Consumer Products & Retail/Beauty & Personal Care/Skincare

Keywords

• Aesthetic medical products
• Dermal fillers distribution
• Botulinum toxin supply
• Regenerative skincare products
• Medical aesthetic distribution

Headquarters

HQ city

Ciudad de Panamá

HQ country

Panama

HQ region

Latin America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Marketing or Sales, Personnel, Operations, Technology or R&D

Revenue model

1. Distribution of Aesthetic Medical Products: Global Skin distributes a portfolio of proprietary and licensed aesthetic medical brands including dermal fillers, botulinum toxin, biostimulators, regenerative skincare, and scar treatment products to medical professionals across Latin America.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Global Skin distributes a portfolio of proprietary and licensed aesthetic medical brands — including dermal fillers, botulinum toxin, biostimulators, regenerative skincare, scar treatment, and dermocosmetic products — to dermatologists, plastic surgeons, and aesthetic physicians across Latin America. The company combines direct field sales with a medical education academy and represents brands such as Fillderm, Nabota, Duraform, Bellalift, SeduSkin, Kelo-cote, Bioage, Simildiet, Promedic, and Olidia. Products are developed and manufactured in France through Laboratoire Global Skin France and backed by clinical studies published in peer-reviewed journals.

Differentiator

Problem solved

Functional benefit

Brands

• SeduSkin: Product line based on advances in regenerative aesthetic medicine, including Hyla-PDRN, Hyladerm, and Hylagen 3 for skin regeneration, repair, and hydration.
• Fillderm
• Nabota
• Bellalift
• Duraform
• Kelo-cote
• Bioage
• Simildiet
• Promedic
• Olidia

Products and services

• Fillderm Dermal Filler Hyaluronic acid-based dermal filler using DCL (Double Cross Linked) technology for facial volume restoration, wrinkle reduction, and lip enhancement, with results lasting 6-8 months and durability exceeding 12 months. Distributed to dermatologists, plastic surgeons, and aesthetic physicians.
• Nabota Botulinum Toxin Type A Ultra-purified botulinum toxin type A at 98.7% purity with FDA, EMA, and KFDA approvals for cosmetic treatment of wrinkles caused by exaggerated muscle hyperactivity. Distributed to dermatologists, plastic surgeons, and aesthetic physicians.
• Duraform Biostimulator Polycaprolactone microspheres and hyaluronic acid biostimulator using ICH (Innovation Concept Hybrid) technology for aesthetic correction of wrinkles, photoaging, and skin laxity, stimulating new collagen fiber production with results evident for more than 2 years post-treatment. Distributed to dermatologists, plastic surgeons, and aesthetic physicians.
• Bellalift Suspension Threads Polycaprolactone suspension threads with three-dimensional bidirectional cones and retaining knots for non-surgical tissue repositioning of fallen or displaced tissue from natural aging, without surgery, scars, or general anesthesia. Distributed to dermatologists, plastic surgeons, and aesthetic physicians.
• Kelo-cote Scar Treatment Gel Topical silicone gel for management and prevention of abnormal scars including keloids and hypertrophic scars resulting from trauma, burns, and surgery; reduces redness, relieves itching, flattens, and reduces elevated appearance and coloration of scars with 24-hour ultra-thin protective barrier treatment. Distributed to medical professionals and available OTC in selected pharmacies.
• SeduSkin Regenerative Product Line Regenerative aesthetic product line including Hyla-PDRN (salmon-derived polidesoxirribonucleotide for facial regeneration), Hyladerm (high and medium molecular weight hyaluronic acid for hydration and firmness), Hylagen 3 (type I and III collagen for skin repair), EXO botanical exosomes (Camellia japonica), EVOLUTION skin booster, and SEDUTOX neuromodulation protocol. Distributed to dermatologists, plastic surgeons, and aesthetic physicians.
• Bioage Dermocosmetic Line Wide line of professional and domestic dermocosmetic products with exclusive actives and superior quality, oriented toward professional and domestic aesthetic care. Distributed to dermatologists, plastic surgeons, aesthetic physicians, and consumers.
• Simildiet Phytotherapeutic and Cosmetic Line Phytotherapeutic and cosmetic product lines with proven therapeutic action, free of adverse effects and contraindications, including peelings, enzymes, and mesotherapy products for facial and body aesthetic treatments. Distributed to dermatologists, plastic surgeons, and aesthetic physicians.
• Promedic Recombinant Enzyme Line Recombinant enzyme-based aesthetic products including Collezyme (collagenase for cellulite treatment) that selectively cleaves amorphous collagen strands around adipocytes in cellulite nodules. Distributed to dermatologists, plastic surgeons, and aesthetic physicians.
• Olidia Aesthetic Product Line Aesthetic product line in the Global Skin distribution portfolio for medical aesthetic professionals. Distributed to dermatologists, plastic surgeons, and aesthetic physicians.
• Lipax Lipolytic Therapy Lipolytic therapy combining deoxycholic acid and phosphatidylcholine for localized fat reduction without affecting metabolic markers or lipid balance. Distributed to dermatologists, plastic surgeons, and aesthetic physicians.

Quantifiable outcome

• Fillderm results last 6-8 months with minor side effects in clinical study of 80 women
• +3 more outcomes

Named customers5 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

Six partnerships are on record, tiered core and minor.

• EsteraphycoreStrategic or Co-development Partner · 9 May 2026Esteraphy is a strategic ally of SeduSkin/Laboratoire Global Skin, co-presenting at Baku Derma 2026 (May 9-10, Baku Convention Center, Azerbaijan) with over 2,000 attending physicians. The partnership showcased EXO++, EXO Folix (botanical exosome lines for skin and hair regeneration), and EVOLUTION skin booster products.
• PROGMEDIC PerucoreChannel Partner/ Reseller/ Distributor · 18 March 2026PROGMEDIC Peru is the local distributor partner for Global Skin/SeduSkin products in Peru. The partnership featured the launch of Lipax (lipolytic therapy) and other aesthetic innovations at an exclusive event at Four Points by Sheraton La Sabana, San José, Costa Rica, led by Dra. Grinilda Amaro with 14+ years in aesthetic medicine.
• KELO-COTE / Kelo-Cote Distribution AgreementminorChannel Partner/ Reseller/ Distributor · 6 October 2022KELO-COTE advanced silicone scar treatment gel is distributed by Global Skin Latinoamerica and available without prescription in selected pharmacies. The product is referenced in medical content about cesarean scar management.
• BIOAGE Brand PartnershipcoreChannel Partner/ Reseller/ DistributorGlobal Skin distributes the BIOAGE professional and domestic dermocosmetic product line with 20 years in the market, oriented toward professional and domestic aesthetic care. BIOAGE invests in continuous studies, technology, and innovation resulting in products with exclusive actives and superior quality.
• Simildiet Brand PartnershipcoreChannel Partner/ Reseller/ DistributorGlobal Skin distributes Simildiet phytotherapeutic and cosmetic product lines with proven therapeutic action, free from adverse effects and contraindications. Includes peelings, enzymes, and mesotherapy products manufactured with high quality standards for facial and body aesthetic treatments.
• Nabota / Daewoong PharmaceuticalcoreChannel Partner/ Reseller/ DistributorNabota ultra-purified botulinum toxin type A (98.7% purity, FDA/EMA/KFDA approved) is distributed by Global Skin across Latin America for cosmetic treatment of wrinkles caused by exaggerated muscle hyperativity.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Galderma: Global dermatology and aesthetics major (Restylane fillers, Sculptra biostimulator, Dysport toxin) operating across all of Latin America with a direct sales force. Direct overlap on every injectable and biostimulator category Global Skin distributes.
• AbbVie (Allergan Aesthetics): Owns the Juvederm filler family, Botox and SkinMedica, the dominant aesthetics platform globally with established LatAm distribution. Competes head-to-head with Global Skin's Fillderm, Nabota and SeduSkin lines.
• Merz Aesthetics: Markets Belotero fillers, Radiesse biostimulator and Xeomin toxin with strong Latin American presence. Closely comparable category mix to Global Skin, particularly versus Fillderm and Duraform.

Direct peers

• Sinclair Pharma: Aesthetics-focused specialty pharma distributing hyaluronic acid fillers (MaiLi), collagen stimulators (Ellansé) and bio-stimulators across Europe and Latin America. Closest comparable regional distribution model and product mix to Global Skin.
• Croma-Pharma: Austrian aesthetics company selling Princess HA fillers, polydioxanone threads and PRP kits through distributor networks including Latin America. Comparable product breadth and channel-driven go-to-market.
• Teoxane: Swiss HA filler specialist (Teosyal range) and skin booster line expanding through regional distributors in Latin America. Overlaps Global Skin on Fillderm-type HA fillers and SeduSkin-type regenerative boosters.
• Laboratoires Vivacy: French aesthetics lab producing Stylage HA fillers and mesotherapy/biostimulator lines (NCTF) with selective Latin American distribution. Closely comparable to Laboratoire Global Skin France's positioning and SKU mix.

Others

• Daewoong Pharmaceutical: Korean pharma company that manufactures Nabota (the flagship botulinum toxin Global Skin distributes). Key upstream principal rather than direct competitor, but its own international aesthetics expansion could eventually disintermediate Global Skin.

Emerging players

• Prollenium Medical Technologies: Canadian manufacturer of the Revanesse line of HA dermal fillers expanding internationally. Comparable emerging-player challenger to Fillderm in regional aesthetics markets.

Regional players

• SKIN Tech Pharma Group: Spanish-based aesthetics and dermocosmetic company with peelings, mesotherapy and biorevitalization products distributed through European and Latin American channels. Comparable portfolio overlap with Simildiet and Bioage professional lines.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCm9gE4zXkQ7rpkqj12RGNwg
• Facebookfacebook.com/globalskinlatam
• Instagraminstagram.com/globalskinlatam

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Global Skin México